1 Rote Liste; Information professionnelle de Dapson-Fatol®. Etat de l’information: Janvier 2015.
2 Coleman MD, et al. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf. 1996;14(6):394–405.
3 Hegesh E, et al. Congenital methemoglobinemia with a deficiency of cytochrome b5. N Engl J Med. 1986;314:757.
4 Prchal JT. Clinical features, diagnosis, and treatment of methemoglobinemia. In: Schrier SL, et al. (eds.). UpToDate. Waltham, MA UptoDate Inc.
http://www.uptodate.com (accès le 25.6.2018).
5 Wright RO, et al. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34(5):646–56.
6 Nast A. et al. Behandlung der Akne, ICD-10 Ziffer: L70; S2k-Leitlinie zur Therapie Akne; S. 60; Deutsche Dermatologische Gesellschaft:
https://www.dermaostschweiz.ch (accès le 24.6.2018).
7 Swartzentruber GS. Methemoglobinemia as a complication of topical dapsone. N Engl J Med. 2015;372:491–2.
8 Gentry Wilkerson R. Getting the blues at a rock concert: a case of severe methaemoglobinaemia. Emerg Med Australas. 2010;22(5):466–9.
9 Olson KR. Poisoning & Drug Overdose. 6th ed. New York: Lange-McGraw-Hill; 2007; p. 280–2 and 510–1.
10 Glader B. Diagnosis and management of glucose-6-phosphate dehydrogenase (G6PD) deficiency. In: Schrier SL, et al. (eds.). UpToDate. Waltham, MA UptoDate Inc.
http://www.uptodate.com (accès le 11.9.2018).
11 Information sur les médicaments Suisse (
www.swissmedicinfo.ch, accès le13.9.2018).
12 Rehman A. et al. Sever acute haemolytic anaemia associated with sever methaemoglobinaemia in a G6PD-deficient man. BMJ Case Reports. 2018. doi:10.1136/bcr-2017-223369.
13 Rauber-Lüthy C. Bleu de méthylène en cas de méthémoglobinémie; ToxInfoSuisse. Juin 2015 (http://toxinfo.ch).